Olga Colomer
Nessuna posizione attualmente
Profilo
Ms. Olga Colomer is Chief Financial Officer at Genmedica Therapeutics SL.
Ms. Colomer was previously employed as Chief Financial Officer by Saudi Basic Industries Corp.
She received her undergraduate degree from Escuela Superior de Administración y Dirección de Empresas.
Precedenti posizioni note di Olga Colomer
| Società | Posizione | Fine |
|---|---|---|
| SABIC | Direttore Finanziario/CFO | - |
Genmedica Therapeutics SL
 Genmedica Therapeutics SL BiotechnologyHealth Technology Genmedica Therapeutics SL engages in the research and development of new treatments for diabetes. Its has developed novel NCE-generating platform to generate dual action, small molecules that act against oxidative stress and inflammation, two specific pathways known to be critical in the root causes of the disease. The company was founded by Alec Humayun Mian and Luc Marti Clauzel on June 21, 2004 and is headquartered in Barcelona, Spain. | Direttore Finanziario/CFO | - |
Formazione di Olga Colomer
| Escuela Superior de Administración y Dirección de Empresas | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SABIC | Process Industries |
| Aziende private | 1 |
|---|---|
Genmedica Therapeutics SL
Genmedica Therapeutics SL BiotechnologyHealth Technology Genmedica Therapeutics SL engages in the research and development of new treatments for diabetes. Its has developed novel NCE-generating platform to generate dual action, small molecules that act against oxidative stress and inflammation, two specific pathways known to be critical in the root causes of the disease. The company was founded by Alec Humayun Mian and Luc Marti Clauzel on June 21, 2004 and is headquartered in Barcelona, Spain. | Health Technology |
- Borsa valori
- Insiders
- Olga Colomer
